ABDX vs. AGL, YGEN, GDR, PRM, VRCI, GENI, DMTR, LLAI, LLA, and IDHC
Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), genedrive (GDR), Proteome Sciences (PRM), Verici Dx (VRCI), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.
Abingdon Health vs.
Abingdon Health (LON:ABDX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations.
ANGLE received 183 more outperform votes than Abingdon Health when rated by MarketBeat users.
Abingdon Health has a net margin of -20.72% compared to ANGLE's net margin of -890.91%. Abingdon Health's return on equity of -62.56% beat ANGLE's return on equity.
ANGLE has a consensus target price of GBX 40, suggesting a potential upside of 321.94%. Given ANGLE's stronger consensus rating and higher probable upside, analysts plainly believe ANGLE is more favorable than Abingdon Health.
33.5% of Abingdon Health shares are owned by institutional investors. Comparatively, 18.8% of ANGLE shares are owned by institutional investors. 48.9% of Abingdon Health shares are owned by company insiders. Comparatively, 16.2% of ANGLE shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, ANGLE's average media sentiment score of 0.00 beat Abingdon Health's score of -1.32 indicating that ANGLE is being referred to more favorably in the news media.
Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.
Abingdon Health has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500.
Summary
Abingdon Health and ANGLE tied by winning 8 of the 16 factors compared between the two stocks.
Get Abingdon Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abingdon Health Competitors List
Related Companies and Tools
This page (LON:ABDX) was last updated on 4/19/2025 by MarketBeat.com Staff
Buy ABDX Stock Free ABDX Stock Alerts